tasisulam
Small moleculeexperimental
Clinical trial activity
13 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
6
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00363766)
Timeline
Indications
Studied for
- Breast Neoplasms · Phase 2
- Carcinoma, Non-Small-Cell Lung · Phase 2
- Carcinoma, Renal Cell · Phase 1
- Fallopian Tube Neoplasms · Phase 2
- Hamartoma · Phase 2
- Leukemia, Myeloid, Acute · Phase 1
- Lymphoma · Phase 1
- Melanoma · Phase 3
- Neoplasms · Phase 1
- Ovarian Neoplasms · Phase 2
- Sarcoma · Phase 2
- Thrombocythemia, Essential · Phase 1
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
O=C(NS(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl- Mol. weight
- 415.12 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110587 ↗
Also known as
- ly573636
- ly573636
- ly573636
- ly573636
- ly 573636
- ly-573636
- ly573636 sodium
- n-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide
- tasisulam
- tasisulam
- tasisulam
- tasisulam
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01209832 | Phase 1 | Sep 1, 2010 | Eli Lilly |
| NCT01185548 | Phase 1 | Jul 1, 2010 | Eli Lilly |
| NCT01006252 | Phase 3 | Dec 1, 2009 | Eli Lilly |
| NCT00992225 | Phase 2 | Sep 1, 2009 | Eli Lilly |
| NCT01214668 | Phase 1 | Jan 1, 2009 | Eli Lilly |
| NCT00718159 | Phase 1 | Aug 1, 2008 | Eli Lilly |
| NCT01284335 | Phase 1 | Jul 1, 2008 | Eli Lilly |
| NCT01258348 | Phase 1 | Jul 1, 2008 | Eli Lilly |
| NCT01215916 | Phase 1 | Feb 1, 2008 | Eli Lilly |
| NCT00490451 | Phase 2 | Aug 1, 2007 | Eli Lilly |
| NCT00428610 | Phase 2 | Feb 1, 2007 | Eli Lilly |
| NCT00383292 | Phase 2 | Nov 1, 2006 | Eli Lilly |
| NCT00363766 | Phase 2 | Sep 1, 2006 | Eli Lilly |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eli Lilly | For profit | 13 | 13 | 3 | 2006 |
1 organizations
Page 1 / 1